Testing effectiveness (Phase 2)WithdrawnNCT02027298
What this trial is testing
Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Who this might be right for
Primary Sjogren's SyndromeSecondary Sjogren's SyndromeInflammatory Arthritis+1 more
The Cleveland Clinic